3 Best Performing ASX shares in week 7, 14 February 2022

Marc Kennis Marc Kennis, February 21, 2022

Best performing ASX shares

This week’s best performing ASX shares are Netlinkz (ASX:NET), up 26.3%, Big River Gold (ASX:BRV), up 25%, and NRW Holdings (ASX:NWH), up 21.5%.

 

1. Netlinkz (ASX:NET)

Industry: Software & IT Services

Netlinkz (ASX:NET) is a networking vendor that provides secure and efficient cloud network solutions. The Netlinkz VSN solution is a NaaS (Network-as-a-Service) proposition that is user-centric, creating a per-user private network that is available, secure and performance optimised, for authorised users regardless of their location.

Market Cap: $70M

12 month high / low: $0.014 – $0.0477

 

Netlinkz

 

 

2. Big River Gold (ASX:BRV)

Industry: Mineral Resources

Big River Gold Limited (BRV, formerly Crusader Resources Limited) is a minerals exploration and development company focused on advancing its wholly-owned Borborema Gold Project in Brazil.

Market Cap: $66M

12 month high / low: $0.20 – $0.46

 

Big River Gold

 

 

3. NRW Holdings (ASX:NWH)

Industry: Industrial & Commercial Services

NRW Holdings Limited (NWH) is an Australian owned Group of companies providing diversified contract services to the resources and infrastructure sectors. Companies within the Group include NRW Civil & Mining, Golding, Action Drill & Blast, RCR Mining Technologies, DIAB Engineering and AES Equipment Solutions.

Market Cap: $952m

12 month high / low: $1.36 – $2.37

 

NRW Holdings

 

 

Learn more about ASX-listed stocks with
Stocks Down Under!

 

Subscribe to Stocks Down Under today!

 

GET A 30-DAY FREE TRIAL

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get the Latest Insider Trades on ASX!

Recent Posts

Nvidia Says US$1T by 2027, Here’s the Hardware Shift It’s Banking On

Nvidia’s US$1T Goal Just Raised the Stakes for Inference Nvidia CEO Jensen Huang has just held the company’s biggest annual…

AML3D (ASX:AL3) Record A$9.9m US Navy Shipbuilder Order Sparks a Rerate

Newport News Doubles Down, Four Arcemy X Systems Ordered AML3D surged today after announcing a A$9.9M contract with the US’s…

T-Cell Lymphoma is a very deadly cancer, but this ASX stock has a treatment in a Phase 2 trial!

  Prescient Therapeutics‘ (ASX:PTX) trial of PTX-100 against T-Cell Lymphoma is well and truly underway now with 8 out of…